Literature DB >> 26590680

Understanding EMPA-REG OUTCOME.

Antonio Ceriello1, Stefano Genovese2, Edoardo Mannucci3, Edoardo Gronda2.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26590680     DOI: 10.1016/S2213-8587(15)00426-X

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  7 in total

Review 1.  Novel Anti-glycemic Drugs and Reduction of Cardiovascular Risk in Diabetes: Expectations Realized, Promises Unmet.

Authors:  James H Flory; Jenny K Ukena; James S Floyd
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

Review 2.  Closing the knowledge gap on cardiovascular disease in type 2 diabetes: the EMPA-REG OUTCOME trial and beyond.

Authors:  Elif A Oral
Journal:  Drugs Context       Date:  2016-09-02

Review 3.  MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review.

Authors:  Eylem Levelt; Gaurav Gulsin; Stefan Neubauer; Gerry P McCann
Journal:  Eur J Endocrinol       Date:  2018-02-12       Impact factor: 6.664

4.  Metabolic Remodeling in Diabetic Cardiomyopathy.

Authors:  Cher-Rin Chong; Kieran Clarke; Eylem Levelt
Journal:  Cardiovasc Res       Date:  2017-02-08       Impact factor: 10.787

Review 5.  Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus.

Authors:  John E Anderson; Eugene E Wright; Charles F Shaefer
Journal:  Diabetes Ther       Date:  2016-11-11       Impact factor: 2.945

Review 6.  Glucagon and heart in type 2 diabetes: new perspectives.

Authors:  Antonio Ceriello; Stefano Genovese; Edoardo Mannucci; Edoardo Gronda
Journal:  Cardiovasc Diabetol       Date:  2016-08-27       Impact factor: 9.951

Review 7.  Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.

Authors:  André J Scheen
Journal:  Circ Res       Date:  2018-05-11       Impact factor: 17.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.